Table 3.
Correlation between STC1 expression and clinicopathologic characteristics of GBM patients.
| Characteristic | Low expression of STC1 | High expression of STC1 | p |
|---|---|---|---|
| n | 84 | 84 | |
| Gender, n (%) | 1.000 | ||
| Female | 30 (17.9%) | 29 (17.3%) | |
| Male | 54 (32.1%) | 55 (32.7%) | |
| Race, n (%) | 0.501 | ||
| Asian | 1 (0.6%) | 4 (2.4%) | |
| Black or African American | 6 (3.6%) | 5 (3%) | |
| White | 75 (45.2%) | 75 (45.2%) | |
| Karnofsky performance score, n (%) | 0.632 | ||
| <80 | 20 (15.6%) | 16 (12.5%) | |
| ≥80 | 45 (35.2%) | 47 (36.7%) | |
| IDH status, n (%) | 0.128 | ||
| WT | 71 (44.1%) | 78 (48.4%) | |
| Mut | 9 (5.6%) | 3 (1.9%) | |
| OS event, n (%) | 0.556 | ||
| Alive | 14 (8.3%) | 18 (10.7%) | |
| Dead | 70 (41.7%) | 66 (39.3%) | |
| DSS event, n (%) | 0.589 | ||
| Alive | 15 (9.7%) | 19 (12.3%) | |
| Dead | 62 (40%) | 59 (38.1%) | |
| PFI event, n (%) | 0.844 | ||
| Alive | 17 (10.1%) | 15 (8.9%) | |
| Dead | 67 (39.9%) | 69 (41.1%) | |
| Age, mean ± SD | 59.18 ± 14.22 | 59.26 ± 12.87 | 0.968 |